OncoNano Medicine, Inc. — Form D/A

OncoNano Medicine, Inc. of Southlake, TX, a company, filed a Form D amendment with the SEC on 2021-11-03. The offering totals $68.4M, of which $68.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2021-11-03
• Form: D/A
• Accession: 0001735726-21-000003
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $68.4M
• Amount sold: $68.4M
• Investors: 27
• Date of first sale: 2020-10-15
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-378478

Issuer

• Name: OncoNano Medicine, Inc.
• CIK: 0001735726
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 550 Reserve Street Suite 190, Southlake, TX, 76092
• Phone: (682) 712-1581

Officers, directors & promoters (25)

Other filings by this issuer (6)

More

• CIK 1735726 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search